← Back to Search

MyTAP oral appliance plus mouth shield for Mild Cognitive Impairment

N/A
Waitlist Available
Research Sponsored by The University of Texas at Dallas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a mouthpiece called MyTAP can improve sleep and brain function in people who are healthy, have mild memory problems, or Alzheimer's disease. The device helps keep the airway open during sleep, which may lead to better memory and thinking skills.

Eligible Conditions
  • Mild Cognitive Impairment
  • Insomnia
  • Cognitive Impairment
  • Alzheimer's Disease
  • Energy Metabolism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change From Baseline: Memory Cognitive Domain Assessed by Montreal Cognitive Test (MoCA)
Secondary study objectives
Executive function cognitive domain improvement after airway management intervention
Memory cognitive domain improvement after airway management intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Cognitively normal adults groupActive Control1 Intervention
A group of cognitively normal adults will be included to investigate whether MyTAP oral airway management with a mouth shield improves sleep and cognition.
Group II: Mild Cognitive Impairment (MCI) groupActive Control1 Intervention
A group of MCI will be included to investigate whether MyTAP oral airway management with a mouth shield improves sleep and cognition.
Group III: Alzheimer's Disease groupActive Control1 Intervention
A group of AD will be included to investigate whether MyTAP oral airway management with a mouth shield improves sleep and cognition.

Find a Location

Who is running the clinical trial?

Texas A & M University Baylor College Of DentistryOTHER
4 Previous Clinical Trials
173 Total Patients Enrolled
University of Texas, Southwestern Medical Center at DallasOTHER
17 Previous Clinical Trials
21,174 Total Patients Enrolled
The University of Texas at DallasLead Sponsor
64 Previous Clinical Trials
106,793 Total Patients Enrolled
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top